Company / CapEx per Share
Boston Scientific CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.59
FY2025
5-year range
$0.33 / $0.59
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#89 of 148
Health Care
What the data says
At $0.59, Boston Scientific's capex per share ranks #89 of 148 in the Health Care sector. CapEx per Share has increased for 5 consecutive years, from $0.23 in FY2020 to $0.59 in FY2025.
Based on SEC 10-K filings.
0.59 in FY2025 with a 5-year CAGR of +21.1%.
Improved from $0.50 to $0.59 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +12.8%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Sector benchmark
#89 of 148 in Health CareTop 60% of 148This company $0.59 Sector average $1.67
▼
-65.0% below sector average
Key checks
Key Insights
- Boston Scientific's capex per share has grown for 5 consecutive years.
- In FY2025, capex per share increased 10.2% year-over-year.
- Ranks #89 out of 148 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.59 | +10.2% |
| FY2024 | $0.53 | +7.2% |
| FY2023 | $0.50 | +21.4% |
| FY2022 | $0.41 | +25.0% |
| FY2021 | $0.33 | +44.9% |
| FY2020 | $0.23 | -31.8% |
| FY2019 | $0.33 | +44.8% |
| FY2018 | $0.23 | -1.7% |
| FY2017 | $0.23 | -16.8% |
| FY2016 | $0.28 | +50.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026